A clinical trial to study the effects of two drugs, Eranda saptaka kwatha and Rasonadi kwatha in patient with pain and stiffness associated with Amavata.

A single blind randomized comparative clinical study to evaluate the efficacy of Eranda saptaka kwatha and Rasonadi kwatha in the management of Stabdhata and Ruja associated with Amavatha. - nil

Status

Recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/10/058245

Enrollment

Registered

2023-10-04

Start date

Unknown

Completion date

Unknown

Last updated

2023-12-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M069- Rheumatoid arthritis, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients of age group above 20 years and below 60 years 2. Patients diagnosed as Amavata on basis of Classical Lakshanas, specifically considering Stabdhata and Ruja for study. 3. Patient with controlled systemic diseases.

Exclusion criteria

Exclusion criteria: 1. Patients below 20 years and above 60 years. 2. Other complicated joint disorders. 3. Complications including deformities, contractures and nodules. 4. Other serious systemic complicated disease.

Design outcomes

Primary

Measure	Time frame
Pain stiffnessTimepoint: 30 days	—

Secondary

Measure	Time frame
not applicableTimepoint: not applicable	—

Countries

India

Contacts

Public ContactDr Samprath Nayak

ALN Rao Memorial Ayurvedic Medical College

drprashanthbhat@outlook.com7619412593

Outcome results